StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2018 it was A$201.17K, up 51.9% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2018Jun 30, 2018A$201.17K+51.9%
FY2017Jun 30, 2017A$132.40K-7.2%
FY2016Jun 30, 2016A$142.66K–

More Alterity Therapeutics figures

See a number that looks wrong?